Addex Therapeutics Ltd./ADR

CIK 2087103 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Addex Therapeutics Ltd./ADR.

Recent SEC filings

FiledFormAccession number
Sep 30, 2025EFFECT9999999995-25-003246
Sep 22, 2025F-60001019155-25-000377